COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, ...

Biden's admin. is poised to effectively ban cigarettes on the way out of the WH with a cartel-friendly rule on lower nicotine levels.

Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...

By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers ...

Part B of the LIGHTHOUSE study will enroll adults and children. DURHAM, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused ...

RSV, walking pneumonia and norovirus among them — is one that you may not have heard of for a while, or perhaps had assumed ...

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to ...

The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...

Since Valisure’s March 2024 report on benzene in acne products, at least six class action lawsuits have been filed against L’Oréal in various jurisdictions. The lawsuits claim BPO products, including ...